Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	14.79	47.81	41.65
Graham Fair Price	-1.37	22.50	22.81
PEG	83.96	-2.03	-12.67
Price/Book	0.57	2.15	2.14
Price/Cash Flow	-97.93	-17.06	823.68
Prices/Earnings	13.40	14.52	12.80
Price/Sales	12.79	2.22	1.97
Price/FCF	-97.93	-17.06	823.68
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	9.33	0.20	0.18
Operating Margin	-0.11	0.06	0.06
ROA	-13.50	0.02	0.02
ROE	0.04	0.04	-11.31
ROIC	0.03	0.02	-11.97
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.12	0.08	56.96
Dividends QOQ	0.01	0.04	305.34
EBIT QOQ	-0.01	-0.08	-448.19
EPS QOQ	-0.01	-0.07	-607.14
FCF QOQ	1.80	-51.22	2739.58
Revenue QOQ	0.02	-0.08	215.41
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	97.76	122.08	24.88
Days Sales Outstanding (DSO)	11.50	14.85	29.14
Inventory Turnover	0.92	0.74	-19.92
Debt/Capitalization	0.46	0.49	5.12
Quick Ratio	0.26	0.26	-0.10
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	23.55	24.66	4.73
Cash	2.31	1.99	-14.09
Capex	-1.00	-1.01	-0.39
Free Cash Flow	0.06	-3.10	4984.23
Revenue	25.54	23.85	-6.62
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.35	1.43	6.03
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	12.04	14.87	23.43
Naive Interpretation	Member

06 - Financial Health · Weak

Rating